[CAS NO. 668467-91-2]  LDN-57444

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [668467-91-2]

Store
Catalog
SLK-S7135
Brand
Selleck
CAS
668467-91-2

DESCRIPTION [668467-91-2]

Overview

MDLMFCD09037562
Molecular Weight397.64
Molecular FormulaC17H11Cl3N2O3
SMILESO=C1N(CC2=CC(Cl)=CC=C2Cl)C3=C(C=C(Cl)C=C3)/C1=N/OC(C)=O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.5148 mL12.5742 mL25.1484 mL
5 mM0.5030 mL2.5148 mL5.0297 mL
10 mM0.2515 mL1.2574 mL2.5148 mL
50 mM---

Description

LDN-57444 is a reversible, competitive inhibitor for Uch-L1 with of 0.88 μM, 28-fold selectivity over isoform Uch-L3.

Targets

UCH-L1 [1]UCH-L1 [1]UCH-L3 [1]
0.4 μM(Ki)0.88 μM25 μM

In vitro

Treatment with 50 μM LDN-57444 for 24 h leads to 70% inhibition of the proteasome activity. LDN-57444 causes a significant and concentration-dependent decrease in cell viability at concentrations above 25 μM and the cell viability reduced to 61.81% at 50 μM. LDN-57444 is able to cause cell death through the apoptosis pathway by decreasing the activity of ubiquitin proteasome system and increasing the levels of highly ubiquitinated proteins, both of which can activate unfolded protein response. The apoptosis induced by LDN-57444 may be triggered by the activation of endoplasmic reticulum stress (ERS).

In vivo

LDN-57444 causes dramatic alterations in synaptic protein distribution and spine morphology in vivo. Treatment with LDN also results in a rapid fall of Uch-L1 activity, but proteasome inhibition has no effect on cAMP levels over a period of several hours.